Hypoxia preconditioned bone marrow mesenchymal stem cells promote liver regeneration in a rat massive hepatectomy model

Stem Cell Research and Therapy

Volumn 4, Issue 4, 2013, Pages

  Yu, Jun ^a   Yin, Shengyong ^a   Zhang, Wu ^a   Gao, Feng ^a   Liu, Yuanxing ^a   Chen, Zhiyun ^a   Zhang, Min ^a   He, Jiangjuan ^a   Zheng, Shusen ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Bone marrow mesenchymal stem cell; Hypoxia preconditioning; Liver regeneration

Indexed keywords

CYCLIN D1; MESSENGER RNA; SERUM ALBUMIN; VASCULOTROPIN;

ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHROPOMETRIC PARAMETERS; ARTICLE; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYCLIN D1 GENE; DNA SYNTHESIS; GENE EXPRESSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; LIVER HOMOGENATE; LIVER INJURY; LIVER REGENERATION; LIVER RESECTION; LIVER WEIGHT BODY WEIGHT RATIO; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SURVIVAL RATE; SURVIVAL TIME; UPREGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR GENE; ANIMAL; BONE MARROW CELL; CELL HYPOXIA; DISEASE MODEL; DRUG EFFECTS; MESENCHYMAL STROMA CELL; METABOLISM; PROCEDURES; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; BONE MARROW CELLS; CELL HYPOXIA; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; HEPATECTOMY; LIVER REGENERATION; MALE; MESENCHYMAL STROMAL CELLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84880125067     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt234     Document Type: Article

References (37)

1. Mesenchymal stem cells in health and disease. Uccelli A, Moretta L, Pistoia V, Nat Rev Immunol 2008 8 726 736 10.1038/nri2395 19172693
2. Mesenchymal stem cells as therapeutics. Parekkadan B, Milwid JM, Annu Rev Biomed Eng 2010 12 87 117 10.1146/annurev-bioeng-070909-105309 20415588
3. Stem/progenitor cells in liver injury repair and regeneration. Zhao Q, Ren H, Zhu D, Han Z, Biol Cell 2009 101 557 571 19642968
4. The use of stem cells in liver disease. Flohr TR, Bonatti H Jr, Brayman KL, Pruett TL, Curr Opin Organ Transplant 2009 14 64 71 10.1097/MOT. 0b013e328320fd7b 19337149
5. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC, Yang VW, Lee OK, Gastroenterology 2008 134 2111 2121 2121.e1-e3 10.1053/j.gastro.2008.03.015 18455168
6. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, Baharvand H, Ghavamzadeh A, Malekzadeh R, Arch Iran Med 2007 10 459 466 17903050
7. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Kharaziha P, Hellstrom PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, Telkabadi M, Atashi A, Honardoost M, Zali MR, Soleimani M, Eur J Gastroenterol Hepatol 2009 21 1199 1205 10.1097/MEG.0b013e32832a1f6c 19455046
8. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Peng L, Xie DY, Lin BL, Liu J, Zhu HP, Xie C, Zheng YB, Gao ZL, Hepatology 2011 54 820 828 10.1002/hep.24434 21608000
9. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Olson S, Grompe M, Nature 2003 422 897 901 10.1038/nature01531 12665832
10. Little evidence for developmental plasticity of adult hematopoietic stem cells. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL, Science 2002 297 2256 2259 10.1126/science.1074807 12215650
11. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, Yarmush ML, Hepatology 2008 47 1634 1643 10.1002/hep.22236 18395843
12. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE, Circ Res 2004 94 678 685 10.1161/01.RES.0000118601.37875.AC 14739163
13. Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Al-Khaldi A, Al-Sabti H, Galipeau J, Lachapelle K, Ann Thorac Surg 2003 75 204 209 10.1016/S0003-4975(02) 04291-1 12537217
14. VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. Tang JM, Wang JN, Zhang L, Zheng F, Yang JY, Kong X, Guo LY, Chen L, Huang YZ, Wan Y, Chen SY, Cardiovasc Res 2011 91 402 411 10.1093/cvr/cvr053 21345805
15. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Deuse T, Peter C, Fedak PW, Doyle T, Reichenspurner H, Zimmermann WH, Eschenhagen T, Stein W, Wu JC, Robbins RC, Schrepfer S, Circulation 2009 120 247 S254 10.1161/CIRCULATIONAHA.108.843680 19752375
16. Bone marrow mononuclear cells and acute myocardial infarction. Arnous S, Mozid A, Martin J, Mathur A, Stem Cell Res Ther 2012 3 2 10.1186/scrt93 22264393
17. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, Gerber HP, Hillan KJ, Ferrara N, Science 2003 299 890 893 10.1126/science.1079562 12574630
18. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Ding BS, Nolan DJ, Butler JM, James D, Babazadeh AO, Rosenwaks Z, Mittal V, Kobayashi H, Shido K, Lyden D, Sato TN, Rabbany SY, Rafii S, Nature 2010 468 310 315 10.1038/nature09493 21068842
19. Human mesenchymal stem cells stimulated by TNF-, LPS, or hypoxia produce growth factors by an NFκB- but not JNK-dependent mechanism. Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, Meldrum DR, Am J Physiol Cell Physiol 2008 294 675 C682 10.1152/ajpcell.00437.2007 18234850
20. Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Annabi B, Lee YT, Turcotte S, Naud E, Desrosiers RR, Champagne M, Eliopoulos N, Galipeau J, Beliveau R, Stem Cells 2003 21 337 347 10.1634/stemcells.21-3-337 12743328
21. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Rosova I, Dao M, Capoccia B, Link D, Nolta JA, Stem Cells 2008 26 2173 2182 10.1634/stemcells.2007-1104 18511601
22. Marginal hepatectomy in the rat: from anatomy to surgery. Madrahimov N, Dirsch O, Broelsch C, Dahmen U, Ann Surg 2006 244 89 98 10.1097/01.sla. 0000218093.12408.0f 16794393
23. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Livak KJ, Schmittgen TD, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609
24. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. Hu X, Yu SP, Fraser JL, Lu Z, Ogle ME, Wang JA, Wei L, J Thorac Cardiovasc Surg 2008 135 799 808 10.1016/j.jtcvs.2007.07.071 18374759
25. Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Chacko SM, Ahmed S, Selvendiran K, Kuppusamy ML, Khan M, Kuppusamy P, Am J Physiol Cell Physiol 2010 299 1562 C1570 10.1152/ajpcell.00221.2010 20861473
26. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Sadat S, Gehmert S, Song YH, Yen Y, Bai X, Gaiser S, Klein H, Alt E, Biochem Biophys Res Commun 2007 363 674 679 10.1016/j.bbrc.2007.09.058 17904522
27. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL, Circulation 2004 109 1292 1298 10.1161/01.CIR.0000121425.42966.F1 14993122
28. The antiapoptotic effect of mesenchymal stem cell transplantation on ischemic myocardium is enhanced by anoxic preconditioning. He A, Jiang Y, Gui C, Sun Y, Li J, Wang JA, Can J Cardiol 2009 25 353 358 10.1016/S0828-282X(09) 70094-7 19536376
29. Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. Chang CP, Chio CC, Cheong CU, Chao CM, Cheng BC, Lin MT, Clin Sci (Lond) 2013 124 165 176 10.1042/CS20120226
30. Salvage effect of the vascular endothelial growth factor on chemically induced acute severe liver injury in rats. Namisaki T, Yoshiji H, Kojima H, Yoshii J, Ikenaka Y, Noguchi R, Sakurai S, Yanase K, Kitade M, Yamazaki M, Asada K, Uemura M, Nakamura M, Fukui H, J Hepatol 2006 44 568 575 10.1016/j.jhep.2005.08.018 16310882
31. Liver regeneration is an angiogenesis-associated phenomenon. Drixler TA, Vogten MJ, Ritchie ED, van Vroonhoven TJ, Gebbink MF, Voest EE, Borel Rinkes IH, Ann Surg 2002 236 703 711 discussion 711-712 10.1097/00000658-200212000-00002 12454508
32. Endothelial-directed hepatic regeneration after partial hepatectomy. Greene AK, Wiener S, Puder M, Yoshida A, Shi B, Perez-Atayde AR, Efstathiou JA, Holmgren L, Adamis AP, Rupnick M, Folkman J, O'Reilly MS, Ann Surg 2003 237 530 535 12677150
33. Liver regeneration. Michalopoulos GK, J Cell Physiol 2007 213 286 300 10.1002/jcp.21172 17559071
34. Pituitary adenylate cyclase-activating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells. Gloddek J, Pagotto U, Paez Pereda M, Arzt E, Stalla GK, Renner U, J Endocrinol 1999 160 483 490 10.1677/joe.0.1600483 10076194
35. Regulation of vascular endothelial growth factor expression by insulin-like growth factor I in thyroid carcinomas. Poulaki V, Mitsiades CS, McMullan C, Sykoutri D, Fanourakis G, Kotoula V, Tseleni-Balafouta S, Koutras DA, Mitsiades N, J Clin Endocrinol Metab 2003 88 5392 5398 10.1210/jc.2003- 030389 14602779
36. No contribution of multipotent mesenchymal stromal cells to liver regeneration in a rat model of prolonged hepatic injury. Popp FC, Slowik P, Eggenhofer E, Renner P, Lang SA, Stoeltzing O, Geissler EK, Piso P, Schlitt HJ, Dahlke MH, Stem Cells 2007 25 639 645 17110617
37. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, Kato T, Okochi H, Ochiya T, J Gastroenterol Hepatol 2009 24 70 77 10.1111/j.1440-1746.2008.05496.x 18624899